- Home
- BEDU vs IXHL Comparison
BEDU vs IXHL Comparison
Compare BEDU & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BEDU | IXHL |
|---|---|---|
| Founded | 1994 | 2001 |
| Country | United Kingdom | Australia |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.0M | 49.1M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | BEDU | IXHL |
|---|---|---|
| Price | $2.19 | $0.47 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.8K | ★ 23.0M |
| Earning Date | 01-23-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $224,321,752.00 | $12,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.35 | $0.08 |
| 52 Week High | $2.28 | $2.25 |
Technical Indicators
Market Signals| Indicator | BEDU | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 57.57 | 65.06 |
| Support Level | $2.14 | $0.35 |
| Resistance Level | $2.22 | $0.50 |
| Average True Range (ATR) | 0.03 | 0.03 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 43.75 | 82.21 |
Price Performance
Historical ComparisonAbout BEDU Bright Scholar Education Holdings Limited each representing four
Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom and the United States. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.